JP2009502196A5 - - Google Patents

Download PDF

Info

Publication number: JP2009502196A5
Authority: JP; Japan
Prior art keywords: seq; complement; oligonucleotides; nucleotides; oligonucleotide
Prior art date: 2006-07-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP2008525040A

Other languages

English (en)

Japanese (ja)

Other versions

JP2009502196A (ja

Filing date

2006-07-25

Publication date

2009-09-10

2005-10-06 Priority claimed from US11/246,904 external-priority patent/US7892795B2/en

2006-07-25 Application filed filed Critical

2009-01-29 Publication of JP2009502196A publication Critical patent/JP2009502196A/ja

2009-09-10 Publication of JP2009502196A5 publication Critical patent/JP2009502196A5/ja

Status Pending legal-status Critical Current

Links

150000007523 nucleic acids Chemical class 0.000 claims description 6
230000003321 amplification Effects 0.000 claims description 3
238000003199 nucleic acid amplification method Methods 0.000 claims description 3
238000001514 detection method Methods 0.000 claims description 2
108091034117 Oligonucleotide Proteins 0.000 claims 19
238000000034 method Methods 0.000 claims 18
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 11
230000000295 complement effect Effects 0.000 claims 11
239000002773 nucleotide Substances 0.000 claims 10
125000003729 nucleotide group Chemical group 0.000 claims 10
108020004707 nucleic acids Proteins 0.000 claims 5
102000039446 nucleic acids Human genes 0.000 claims 5
241000829111 Human polyomavirus 1 Species 0.000 claims 4
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 3
238000009396 hybridization Methods 0.000 claims 3
241000701460 JC polyomavirus Species 0.000 claims 2
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
239000000523 sample Substances 0.000 description 4
238000003556 assay Methods 0.000 description 3
108091028043 Nucleic acid sequence Proteins 0.000 description 1

JP2008525040A 2005-08-02 2006-07-25 Ｂｋウイルス検出のための方法および組成物 Pending JP2009502196A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US70521705P	2005-08-02	2005-08-02
US11/246,904 US7892795B2 (en)	2005-08-02	2005-10-06	Methods and compositions for detecting BK virus
PCT/US2006/029243 WO2007016275A2 (en)	2005-08-02	2006-07-25	Methods and compositions for detecting bk virus

Publications (2)

Publication Number	Publication Date
JP2009502196A JP2009502196A (ja)	2009-01-29
JP2009502196A5 true JP2009502196A5 (2)	2009-09-10

Family

ID=37709186

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2008525040A Pending JP2009502196A (ja)	2005-08-02	2006-07-25	Ｂｋウイルス検出のための方法および組成物

Country Status (8)

Country	Link
US (4)	US7892795B2 (2)
EP (2)	EP1910578B1 (2)
JP (1)	JP2009502196A (2)
CN (3)	CN110423844B (2)
AU (1)	AU2006275803B2 (2)
CA (1)	CA2617635C (2)
ES (1)	ES2552725T3 (2)
WO (1)	WO2007016275A2 (2)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7892795B2 (en) *	2005-08-02	2011-02-22	Focus Diagnostics, Inc.	Methods and compositions for detecting BK virus
US20090246754A1 (en) *	2008-02-19	2009-10-01	Intelligent Mdx	Optimized probes and primers and methods of using same for the detection and quantitation of bk virus
KR20110011600A (ko) *	2008-02-20	2011-02-08	이와키, 코수케, 켄	폴리오마바이러스 검출
US20090258342A1 (en) *	2008-04-09	2009-10-15	Intelligent Medical Devices, Inc.	Optimized probes and primers and methods of using same for the detection, quantification and grouping of hiv-1
CN102344970B (zh) *	2010-07-27	2013-01-23	温州医学院附属第一医院	同时检测人cmv和bk病毒dna的引物序列及定量检测试剂盒
CN102154523B (zh) *	2011-04-07	2013-01-02	温岭市第一人民医院	检测人bk病毒核酸的引物与荧光探针及其应用
CN102690894B (zh) *	2011-06-08	2013-05-01	中国人民解放军第三〇九医院	一种bk病毒的检测方法、其试剂盒及应用
CN103093120A (zh) *	2011-11-08	2013-05-08	北京健数通生物计算技术有限公司	高通量检测脊椎动物病原体基因芯片的探针设计方法
CN104745723A (zh) *	2015-01-30	2015-07-01	湖北永邦医疗科技有限公司	一种用于检测bk病毒的引物、探针和试剂盒
US10793923B2 (en) *	2016-11-09	2020-10-06	Roche Molecular Systems, Inc.	Compositions and methods for detection of BK virus
JP7532257B2 (ja) *	2018-03-02	2024-08-13	アカデミシュ・ジークンホイス・ライデン・ハー・オー・デー・エン・ライドス・ユニヴェルシタイル・メディシュ・セントルム	ポリオーマウイルス複製の阻害
FR3082524B1 (fr) *	2018-06-18	2022-03-25	Univ Paris Sud	Methode de stratification du risque de nephropathie a bk-virus apres transplantation renale
WO2020086546A1 (en) *	2018-10-22	2020-04-30	Gen-Probe Incorporated	Compositions and methods for amplifying, detecting or quantifying human polyomavirus bk virus
KR102347899B1 (ko) *	2019-06-21	2022-01-06	울산대학교 산학협력단	신장이식 후 bk 바이러스 신병증의 진단 또는 예후 예측을 위한 소변 엑소좀 바이오마커
CN111733298B (zh) *	2020-08-25	2020-11-20	圣湘生物科技股份有限公司	检测多瘤病毒并分型的组合物、试剂盒、方法及其用途
TWI833069B (zh)	2021-03-17	2024-02-21	國防醫學院	核酸探針組、核酸側流檢測套組以及該核酸側流檢測套組之用途
CN114107571B (zh) *	2022-01-18	2024-06-21	复旦大学附属中山医院	用于bk病毒lamp检测的试剂盒
CN115029485A (zh) *	2022-06-20	2022-09-09	广东永诺医疗科技有限公司	一种基于微滴式数字pcr的bkv病毒检测试剂盒

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4318846A (en)	1979-09-07	1982-03-09	Syva Company	Novel ether substituted fluorescein polyamino acid compounds as fluorescers and quenchers
US4458066A (en)	1980-02-29	1984-07-03	University Patents, Inc.	Process for preparing polynucleotides
US4415732A (en)	1981-03-27	1983-11-15	University Patents, Inc.	Phosphoramidite compounds and processes
US4605735A (en)	1983-02-14	1986-08-12	Wakunaga Seiyaku Kabushiki Kaisha	Oligonucleotide derivatives
US4683202A (en)	1985-03-28	1987-07-28	Cetus Corporation	Process for amplifying nucleic acid sequences
US4683195A (en)	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4757141A (en)	1985-08-26	1988-07-12	Applied Biosystems, Incorporated	Amino-derivatized phosphite and phosphate linking agents, phosphoramidite precursors, and useful conjugates thereof
US4889818A (en)	1986-08-22	1989-12-26	Cetus Corporation	Purified thermostable enzyme
US5541308A (en) *	1986-11-24	1996-07-30	Gen-Probe Incorporated	Nucleic acid probes for detection and/or quantitation of non-viral organisms
US5283174A (en)	1987-09-21	1994-02-01	Gen-Probe, Incorporated	Homogenous protection assay
US5639604A (en)	1987-09-21	1997-06-17	Gen-Probe Incorporated	Homogeneous protection assay
US6004745A (en)	1987-09-21	1999-12-21	Gen-Probe Incorporated	Hybridization protection assay
US5585481A (en)	1987-09-21	1996-12-17	Gen-Probe Incorporated	Linking reagents for nucleotide probes
US4914210A (en)	1987-10-02	1990-04-03	Cetus Corporation	Oligonucleotide functionalizing reagents
US5185439A (en)	1987-10-05	1993-02-09	Gen-Probe Incorporated	Acridinium ester labelling and purification of nucleotide probes
CA1340807C (en)	1988-02-24	1999-11-02	Lawrence T. Malek	Nucleic acid amplification process
JP2650159B2 (ja)	1988-02-24	1997-09-03	アクゾ・ノベル・エヌ・ベー	核酸増幅方法
US5849481A (en)	1990-07-27	1998-12-15	Chiron Corporation	Nucleic acid hybridization assays employing large comb-type branched polynucleotides
US5213796A (en)	1991-05-06	1993-05-25	Dana Farber Cancer Institute	Assay for polyomavirus in humans and uses thereof
US5538848A (en)	1994-11-16	1996-07-23	Applied Biosystems Division, Perkin-Elmer Corp.	Method for detecting nucleic acid amplification using self-quenching fluorescence probe
US6127121A (en) *	1998-04-03	2000-10-03	Epoch Pharmaceuticals, Inc.	Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
WO2001066148A1 (en)	2000-03-08	2001-09-13	Neurosearch A/S	A method of sensitising endothelial cells to prodrugs
US6605602B1 (en) *	2001-09-28	2003-08-12	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	Method of treating BK virus nephropathy
BRPI0214741B1 (pt) *	2001-12-08	2015-05-12	Seegene Inc	Iniciador de controle de anelamento para melhorar a especificidade de anelamento na amplificação de ácido nucléico, Kit, Métodos para amplificar seqüências de ácido nucléico de um DNA e seqüência de ácido nucléico alvo ou uma mistura de ácidos nucléicos, para detectar a complementaridade de DNA ao mRNA diferencialmente expresso em duas ou mais amostras de ácido nucléico, para amplificar rapidamente um fragmento de CDNA alvo, para amplificar uma população de CDNAs de filamento duplo de comprimento completo complementar aos mRNAS, e CDNAs de filamento duplo enriquecidos em 5 complementares aos mRNAS, para amplificar mais do que uma seqüência de nucleotídeo alvo simultaneamente, para produzir uma impressão digital de DNA de gDNA, e de RNA de uma amostra de mRNA, para identificar segmentos de homologia conservada em uma família de multigene a partir de uma amostra de mRNA, para identificar uma variação de nucleotídeo em um ácido nucléico alvo, para a mutagênese em um ácido nucléico alvo, e, uso do iniciador
US7892795B2 (en) *	2005-08-02	2011-02-22	Focus Diagnostics, Inc.	Methods and compositions for detecting BK virus
WO2007127919A2 (en) *	2006-04-28	2007-11-08	Alnylam Pharmaceuticals, Inc.	Compositions and methods for inhibiting expression of a gene from the jc virus
US20080003565A1 (en) *	2006-05-02	2008-01-03	Government Of The Us, As Represented By The Secretary, Department Of Health And Human Services	Viral nucleic acid microarray and method of use

2005
- 2005-10-06 US US11/246,904 patent/US7892795B2/en active Active
2006
- 2006-07-25 AU AU2006275803A patent/AU2006275803B2/en active Active
- 2006-07-25 WO PCT/US2006/029243 patent/WO2007016275A2/en not_active Ceased
- 2006-07-25 EP EP06788689.5A patent/EP1910578B1/en active Active
- 2006-07-25 CN CN201910529553.9A patent/CN110423844B/zh active Active
- 2006-07-25 JP JP2008525040A patent/JP2009502196A/ja active Pending
- 2006-07-25 CN CN200680034771.6A patent/CN101511995B/zh active Active
- 2006-07-25 CA CA2617635A patent/CA2617635C/en active Active
- 2006-07-25 CN CN201510303094.4A patent/CN104862422B/zh active Active
- 2006-07-25 EP EP12196497.7A patent/EP2662456A1/en not_active Withdrawn
- 2006-07-25 ES ES06788689.5T patent/ES2552725T3/es active Active
2011
- 2011-01-12 US US13/005,490 patent/US8748092B2/en active Active
2014
- 2014-04-29 US US14/264,462 patent/US9745638B2/en not_active Expired - Lifetime
2017
- 2017-08-22 US US15/683,036 patent/US10801078B2/en not_active Expired - Lifetime

Publication	Publication Date	Title
JP2009502196A5 (2)	2009-09-10
Shen et al.	2020	Recent advances and perspectives of nucleic acid detection for coronavirus
EP2140033B1 (en)	2012-10-10	System and method for high resolution analysis of nucleic acids to detect sequence variations
JP2012518421A5 (2)	2013-04-18
JP6595629B2 (ja)	2019-10-23	ウイルス性出血性敗血症ウイルスの地域特異的遺伝型の判別用プローブ及びその用途
JP2013055956A5 (2)	2013-07-04
JP2005511004A5 (2)	2006-01-05
JP2002539848A5 (2)	2007-09-20
JP2009533066A5 (2)	2011-04-28
JP2010227103A5 (2)	2011-05-19
JP7819171B2 (ja)	2026-02-24	Ｈｅｖ核酸を検出するための組成物および方法
WO2013116039A1 (en)	2013-08-08	Amplification primers and probes for detection of hiv-1
JP2017522015A5 (2)	2018-08-02
JP2024003255A5 (2)	2024-06-05
KR100738082B1 (ko)	2007-07-12	핵산 프라이머 세트, 핵산 프로브 세트 및 그들을 이용한호흡기 질환 바이러스의 검출방법
Nishimura et al.	2010	Detection of noroviruses in fecal specimens by direct RT-PCR without RNA purification
JP2009518001A5 (2)	2011-01-27
JP2018516594A5 (2)	2019-06-13
WO2002064842A3 (en)	2003-12-18	Quantitative epstein barr virus pcr rapid assay
WO2010092595A2 (en)	2010-08-19	Oligonucleotide probes and primers for detection of hepatitis b virus
CN104321443A (zh)	2015-01-28	Hev测定
CN101379196B (zh)	2012-10-24	用于鉴定临床样品中的人乳头瘤病毒的体外诊断试剂盒
ES2675725T3 (es)	2018-07-12	Composiciones y procedimientos para la hibridación de ácidos nucleicos
JP2009502190A5 (2)	2009-09-24
WO2018005284A1 (en)	2018-01-04	Methods and compositions for influenza a virus subtyping